1. Balmaña, J., Sanz, J., Bonfill, X., Casado, A., Rué, M., Gich, I., Díez, O., Sabaté, J.M., Baiget, M., Alonso, M.C.: Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Int. J. Cancer 112(4), 647–652 (2004)
2. Barré, S., Préaubert, N., Delaveyne, R., Cecchin, M.: An economic evaluation of screening for hereditary haemochromatosis in the French population. Journal d’Economie Médicale 23(1), 15–26 (2005)
3. Barrow, E., McMahon, R., Evans, D.G., Levine, E., Hill, J.: Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer. Br. J. Surg. 95(7), 868–875 (2008)
4. Brain, K., Gray, J., Norman, P., France, E., Anglim, C., Barton, G., Parsons, E., Clarke, A., Sweetland, H., Tischkowitz, M., Myring, J., Stansfield, K., Webster, D., Gower-Thomas, K., Daoud, R., Gateley, C., Monypenny, I., Singhal, H., Branston, L., Sampson, J., Roberts, E., Newcombe, R., Cohen, D.: Randomized trial of a specialist genetic assessment service for familial breast cancer. J. Natl Cancer Inst. 92(16), 1345–1351 (2000)
5. Caballero Villarraso J., Villegas Portero R. “Denaturing high performance liquid chromatography (DHPLC). Use and utility in massive genotyping”. Andalusian Agency for Health Technology Assessment (AETSA) 2006/2007